Kezar Life Sciences buy BiotechBee
Start price
07.09.22
/
80%
€9.70
Target price
31.12.24
€20.00
Performance (%)
-76.29%
End price
05.05.23
€2.30
Summary
This prediction ended on 05.05.23 with a price of €2.30. The BUY prediction by BiotechBee for Kezar Life Sciences performed very badly with a performance of -76.29%. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kezar Life Sciences | - | - | - | - |
| iShares Core DAX® | 4,85 % | -2,75 % | 13,10 % | 46,79 % |
| iShares Nasdaq 100 | 4,00 % | -3,33 % | 31,34 % | 76,98 % |
| iShares Nikkei 225® | 4,22 % | -2,91 % | 44,47 % | 49,88 % |
| iShares S&P 500 | 3,32 % | -2,95 % | 24,36 % | 57,27 % |
According to BiotechBee what are the pros and cons of Kezar Life Sciences for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Kezar Life Sciences diskutieren
Buy mit Kursziel 20,0